Pure Global AI
NCT05935865Recruiting

Monitoring of the Influence of Approved PH-therapies RV-PA Coupling

University of GiessenClinicalTrials.gov
Verified
Study focus
Disease/Condition
Pulmonary Hypertension
Study type
Observational
Sponsor & location
Primary sponsor
University of Giessen
Location
Giessen, Germany
Timeline & enrollment
Phase
N/A
Start date
Feb 13, 2023
End date
Feb 13, 2026
Enrollment
100 participants
Primary outcome

Afterload,Contractility,Coupling,Validation of Echo/CorLog PV-Loops

Summary

The goal of this observational study is to learn about the acute (days) changes in right
 ventricular functions caused by initiation of pharmacological therapies in patients with
 precapillary pulmonary hypertension. The main question it aims to answer is:
 
 • Course of afterload and intrinsic contractility throughout the hospital stay Participants
 will be equipped with a device for continuous monitoring and recording of the right
 ventricular pressure signal.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05935865
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05935865 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Giessen and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.